HumaScan
This article was originally published in The Gray Sheet
Executive Summary
Donald Brounstein resigns as president and CEO of the Cranford, New Jersey firm May 19. Since founding the company in 1995, Brounstein managed the development and recent launch of the firm's Breast Alert breast cancer detection device ("The Gray Sheet" Nov. 17, In Brief). Elizabeth Tallett replaces Brounstein on an interim basis as chairman and acting CEO until a permanent replacement is found. Tallett maintains responsibilities as president and CEO of two start-up companies: Dioscor, a biotech management company and Ellard Pharmaceuticals...